EXPANDED ACCESS DATA IMPACT ON NDAs SHOULD BE ASSESSED BY FDA, REFORM BILL CONFERENCE REPORT STATES; "FAST TRACK" PROVISIONS CODIFY ACCELERATED APPROVAL